FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.

DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...

Glucose is a type of sugar people receive from food, and it's the body's main source of energy. Continuous glucose monitors, or CGMs, are small sensors that poke through the skin to measure glucose ...

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration has approved Dexcom's Stelo Glucose Biosensor System, the first over-the-counter continuous ...

Over-the-counter continuous glucose monitors have moved from a diabetes-only tool into the broader metabolic health conversation, and shoppers now face a real decision. Here is an OTC CGM comparison ...

Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it's the ...